Clinical Interventions in Aging, 1 (4), 307-308
A provider-guided plan can help reduce risk by reviewing eligibility, sourcing, timing, monitoring, and side effects
This applies most strongly to first-generation GHK-CU
BEST (Biomarkers, EndpointS, and other Tools) Resource
If it is approved, Ryan said it will be important to monitor the drug for safety in the real-world population during the postmarketing surveillance period, as real-world populations differ from people enrolled in a clinical trial
Our findings indicate GH as a starvation signal that alerts the brain about energy deficiency, triggering key adaptive responses to conserve limited fuel stores